Risk Factors of Anemia in Pulmonary Arterial Hypertension Patients with Endothelin Receptor Antagonists Administration and Related Treatment

被引：0
|
作者：
Xin, Li
Zhao, Zhihui
Luo, Qin
Zhao, Qing
Jin, Qi
Zhang, Yi
Huang, Zhihua
Duan, Anqi
Zhang, Sicheng
Gao, Luyang
Wang, Yijia
Li, Sicong
Liu, Zhihong
机构：
来源：
CIRCULATION | 2024年 / 150卷
关键词：
D O I：
10.1161/circ.150.suppl_1.4119891
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4119891
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Endothelin receptor antagonists for pulmonary arterial hypertension and COVID-19: Friend or foe?
    Badagliacca, Roberto
    Sciomer, Susanna
    Petrosillo, Nicola
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2020, 39 (07): : 729 - 730
  • [42] Systematic Review of Randomized Controlled Trials of Endothelin Receptor Antagonists for Pulmonary Arterial Hypertension
    Kuntz, Michael
    Leiva-Juarez, Miguel M.
    Luthra, Suvitesh
    LUNG, 2016, 194 (05) : 723 - 732
  • [43] A network meta-analysis for safety of endothelin receptor antagonists in pulmonary arterial hypertension
    Zhang, Yi-Jing
    Wang, Na
    Gu, Zhi-Chun
    Wei, An-Hua
    Cheng, An-Ni
    Fang, Sha-Sha
    Du, Hong-Li
    Wang, Lin-Zhao
    Zhang, Guo-Qing
    CARDIOVASCULAR DIAGNOSIS AND THERAPY, 2019, 9 (03) : 239 - +
  • [44] Systematic Review of Randomized Controlled Trials of Endothelin Receptor Antagonists for Pulmonary Arterial Hypertension
    Michael Kuntz
    Miguel M. Leiva-Juarez
    Suvitesh Luthra
    Lung, 2016, 194 : 723 - 732
  • [45] Efficacy, safety and clinical pharmacology of macitentan in comparison to other endothelin receptor antagonists in the treatment of pulmonary arterial hypertension
    Dingemanse, Jasper
    Sidharta, Patricia N.
    Maddrey, Willis C.
    Rubin, Lewis J.
    Mickail, Hani
    EXPERT OPINION ON DRUG SAFETY, 2014, 13 (03) : 391 - 405
  • [46] Riociguat in Combination With Endothelin Receptor Antagonists (ERAs) for the Treatment of Pulmonary Arterial Hypertension (PAH): A Subgroup Analysis of PATENT
    Hill, Nicholas
    Sood, Namita
    CHEST, 2015, 148 (04)
  • [47] Ambrisentan -: Treatment of pulmonary arterial hypertension endothelin ETA receptor antagonist
    Sorbera, LA
    Castañer, J
    DRUGS OF THE FUTURE, 2005, 30 (08) : 765 - 770
  • [48] Treatment of pulmonary arterial hypertension with macitentan, dual endothelin receptor antagonist
    Bichara, Valentina M.
    Bevacqua, Raul J.
    INSUFICIENCIA CARDIACA, 2019, 14 (03) : 119 - 128
  • [49] Advances in the treatment of pulmonary arterial hypertension: focus on endothelin receptor antagonism
    Pittrow, D.
    Kirch, W.
    CURRENT MEDICAL RESEARCH AND OPINION, 2007, 23 : S1 - S2
  • [50] Sitaxsentan: an endothelin-A receptor antagonist for the treatment of pulmonary arterial hypertension
    O'Callaghan, DS
    Gaine, SP
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2006, 60 (04) : 475 - 481
12345